Session » Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II

Date: Monday, November 9, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1733

A Close Correlation Between Radiologic Progression Severity and Trabecular Bone Loss in Male Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1741

Abdominal Fat Mass Assessment in Recent Onset Spondyloarthritis: Data from the DESIR Cohort

9:00AM-11:00AM: Abstract Number: 1724

Abdominal X-Rays Can Reliably Detect the Majority of CT Positive Sacroiliitis in an IBD Cohort

9:00AM-11:00AM: Abstract Number: 1705

Acute Anterior Uveitis in Ankylosing Spondylitis: Association with Inflammatory Bowel Disease and Psoriasis Independent of HLA-B27

9:00AM-11:00AM: Abstract Number: 1694

All-Cause Mortality and Malignancies in Psoriasis Patients with Psoriatic Arthritis in the Psoriasis Longitudinal Assessment and Registry Study

9:00AM-11:00AM: Abstract Number: 1740

Anti-Cyclic Citrullinated Peptide Antibodies and Inflammatory Bowel Disease

9:00AM-11:00AM: Abstract Number: 1738

Assessing the Validity of the Multi-Biomarker Disease Activity Assay in Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1686

Body Mass Index Is Associated with Hip Arthritis in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1719

Can Structural Progression on MRI of Sacroiliac Joints in Patients with Spondyloarthritis be Reliably Detected and What Type of Calibration Is Necessary to Achieve This?

9:00AM-11:00AM: Abstract Number: 1749

Clinical Characteristics of Axial Spondyloarthritis Patients Progressing from Non-Diagnostic to Diagnostic Radiographic Sacroiliitis

9:00AM-11:00AM: Abstract Number: 1707

Comorbidity Burden and Medication Use Among Patients with Psoriatic Arthritis in the US

9:00AM-11:00AM: Abstract Number: 1734

Computer Aided Syndesmophyte Measurement on Spinal Radiographs in Axial Spondyloarthritis Patients

9:00AM-11:00AM: Abstract Number: 1689

Cross Sectional Study Investigating the Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1748

Degenerative Changes at the Lumbar Spine in Patients with Axial Spondyloarthritis and Non-Specific Mechanical Low Back Pain: A Magnetic Resonance Imaging Study

9:00AM-11:00AM: Abstract Number: 1712

Development of a Novel SI Joint CT Score for Diagnosis of Axial Spondylitis

9:00AM-11:00AM: Abstract Number: 1728

Diffusion Weighted Imaging Is a Sensitive and Specific MRI Protocol for the Diagnosis and Assessment of Disease Severity in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1718

Entheseal Abnormalities and Nail Involvement at the Distal Interphalangeal Joints on Ultrasound Examination in Patients with Psoriasis and Psoriatic Arthritis. Could the Nail-Enthesitis Theory be Supported?

9:00AM-11:00AM: Abstract Number: 1711

Enthesitis in Psoriatic Arthritis – Disease Association and Risk Factors

9:00AM-11:00AM: Abstract Number: 1710

Enthesitis in Psoriatic Arthritis: Incidence, Prevalence and Characteristics

9:00AM-11:00AM: Abstract Number: 1717

Factors Associated with the Decision of the Rheumatologist to Order Sacro-Iliac Joints Magnetic Resonance Imaging (SI-MRI) or Order HLA-B27 Testing in Patients with Spondyloarthritis in Clinical Practice

9:00AM-11:00AM: Abstract Number: 1721

Factors Predictive of Radiographic Progression in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1713

Fat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1695

Fatigue May be Independently Active at a Certain Part of Spondyloarthritis Patients: Hur-BIO Real Life Results

9:00AM-11:00AM: Abstract Number: 1690

Fibromyalgia in Spondyloarthritis: Impact on Disease Activity Assessment

9:00AM-11:00AM: Abstract Number: 1742

Fingerprint Biomarkers of Type I and III Collagen in Axial Spondyloarthropathy (axSpA) and Psoriatic Arthritis (PsA). Association with Disease Activity and Diagnostic Capacity

9:00AM-11:00AM: Abstract Number: 1744

Free DKK-1 Serum Levels Are Unchanged in Spondyloarthritis Patients Treated By Etanercept

9:00AM-11:00AM: Abstract Number: 1743

Gender Differences in Ankylosing Spondylitis: Men Derive Greater Benefit from Tumor Necrosis Factor Alpha Inhibitors

9:00AM-11:00AM: Abstract Number: 1730

Good Control of Inflammation Counterbalances a Negative Impact of Radiographic Spinal Progression on Functional Status and Spinal Mobility in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors

9:00AM-11:00AM: Abstract Number: 1693

High Prevalence of Cardiac Disease in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1698

High Prevalence of Traditional Cardiovascular Risk Factors in an Ankylosing Spondylitis Cohort

9:00AM-11:00AM: Abstract Number: 1735

Imaging and Clinical Factors Associated with Subchondral Sacroiliac Fatty Marrow in Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1687

Increased Carotid Intima-Media Thickness in Psoriatic Arthritis Patients Compared with Systemic Lupus Erythematosus Patients and Healthy Controls

9:00AM-11:00AM: Abstract Number: 1737

Increased Osteoclast Precursors with an Elevated DC-STAMP Expression May Identify Psoriasis Patients at Risk for Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1736

Is There Evidence to Support Replacing Conventional AP Pelvis Radiographs with Dedicated Sacroiliac Joint Views for the Diagnosis of Sacroiliitis?

9:00AM-11:00AM: Abstract Number: 1701

Long Term Outcome of Total Hip Replacement in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1684

Malignancies in Patients with Incident Psoriatic Arthritis 1970-2008 in Relation to a Comparator Cohort: A Population-Based Case-Control Study

9:00AM-11:00AM: Abstract Number: 1685

Metabolic Syndrome in Patients with Psoriatic Arthritis Is Associated to Peripheral Disease Activity

9:00AM-11:00AM: Abstract Number: 1727

MRI Vertebral Corner Inflammation Followed By Fat Deposition Is the Strongest Contributor to the Development of New Bone at the Same Vertebral Corner: A Multi-Level Longitudinal Analysis in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1699

Obesity and Pediatric Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1703

Obesity Is Related with Active State in Psoriatic Arthritis and Rheumatoid Arthritis but Not Ankylosing Spondylitis at Real Life Biological Cohort

9:00AM-11:00AM: Abstract Number: 1697

Obstructive Sleep Apnea and Fatigue in Inflammatory Arthritis Patients Taking TNF-Inhibitors

9:00AM-11:00AM: Abstract Number: 1702

Osteoporosis in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1746

Patient’s Ability of Coping Is Influencing the Correlation Between Clinical and Ultrasonographic Evidence of Disease Activity in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1729

Predictors and Clinical Factors Associated with Change in Spinal Inflammation Assessed on MRI over 2 Years: Data from Tasmanian Ankylosing Spondylitis Study

9:00AM-11:00AM: Abstract Number: 1708

Predictors of Depression Severity in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1747

Predictors of Survival on Anti-TNF in an Observational Cohort of Patients with Ankylosing Spondylitis: The Role of MRI Parameters of Inflammation and Structural Damage

9:00AM-11:00AM: Abstract Number: 1745

Predictors of Sustained Remission on Anti-TNF in an Observational Cohort of Patients with Ankylosing Spondylitis: The Role of MRI Parameters of Inflammation and Structural Damage

9:00AM-11:00AM: Abstract Number: 1706

Prevalence and Factors Associated with Non-Traumatic Vertebral Fractures in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1716

Prevalence of Joint Symptoms and Frequency of Joint Exams for Patients with Plaque Psoriasis without Confirmed Psoriatic Arthritis: A US Analysis

9:00AM-11:00AM: Abstract Number: 1704

Prevalence of Obesity and Metabolic Syndrome in Patients with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1723

Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized CT Scoring System

9:00AM-11:00AM: Abstract Number: 1720

Quantitative Assessment of Bone Marrow Fat Using Magnetic Resonance Imaging in Patients with Spondyloarthropathy

9:00AM-11:00AM: Abstract Number: 1731

Radiographic Damage of Facet Joints and Vertebral Bodies in the Cervical Spine in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors

9:00AM-11:00AM: Abstract Number: 1726

Reliability of Radiographic Assessment of Psoriatic Arthritis Mutilans

9:00AM-11:00AM: Abstract Number: 1725

Reliable Evaluation of Structural Lesions of the Sacroiliac Joints on MRI in Patients with Axial Spondyloarthritis That Is Comparable to Evaluation of Inflammation Despite Minimal Calibration

9:00AM-11:00AM: Abstract Number: 1696

Score Classification Underestimates the Real Cardiovascular Risk in Psoriatic Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1715

Sensivity and Specificity of Clinical Criteria to Identify Patients in Ultrasound Remission in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1692

Serious Infections in Psoriasis Patients with Psoriatic Arthritis in the Psoriasis Longitudinal Assessment and Registry Study

9:00AM-11:00AM: Abstract Number: 1732

Slow Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors

9:00AM-11:00AM: Abstract Number: 1700

Subclinical Atherosclerosis in Ankylosing Spondylitis. Does It Really Exist and Which Are the Effects of Treatments? a Systematic Review

9:00AM-11:00AM: Abstract Number: 1709

Subclinical Atherosclerosis in Patients with Psoriatic Arthritis and the Role of Vitamin D

9:00AM-11:00AM: Abstract Number: 1691

The Presence of Fibromialgia May Influence the Clinimetric Evaluation of Patients with Ankylosing Spondylitis, but Has No Impact on Disease Activity Assessment

9:00AM-11:00AM: Abstract Number: 1739

The Ratio of Glycated Hemoglobin A1c (HbA1c) to Glycated Albumin (GA) Is Correlated with Ankylosing Spondylitis Disease Activity Score (ASDAS) in Non-Diabetic Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1688

Trends in Hospitalizations and Charges for Ankylosing Spondylitis, 1993-2012

9:00AM-11:00AM: Abstract Number: 1722

What Is the Clinical Utility of MR Imaging in the Management of Nr-Axspa Patients?

9:00AM-11:00AM: Abstract Number: 1714

Young Patients with Back Pain and Maximally 1 Spa Feature: Is It Useful to Test HLA-B27 or Image the Sacroiliac Joints?

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].